Family Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$85K Buy
+537
New +$72.6K 0.01% 291
2025
Q2
– Sell
-2,064
Closed -$167K – 253
2025
Q1
$167K Hold
2,064
– – 0.03% 179
2024
Q4
$186K Sell
2,064
-1,110
-35% -$108K 0.03% 163
2024
Q3
$314K Sell
3,174
-3,247
-51% -$319K 0.05% 135
2024
Q2
$595K Sell
6,421
-5,824
-48% -$522K 0.1% 92
2024
Q1
$1.16M Buy
12,245
+2,592
+27% +$241K 0.21% 72
2023
Q4
$862K Buy
9,653
+4,544
+89% +$337K 0.18% 69
2023
Q3
$373K Sell
5,109
-825
-14% -$65.9K 0.08% 92
2023
Q2
$494K Buy
5,934
+4,784
+416% +$400K 0.11% 81
2023
Q1
$87.6K Hold
1,150
– – 0.02% 133
2022
Q4
$95.5K Buy
+1,150
New +$93.1K 0.02% 150
2022
Q1
– Sell
-7,009
Closed -$785K – 189
2021
Q4
$785K Buy
7,009
+1,514
+28% +$183K 0.2% 81
2021
Q3
$691K Buy
+5,495
New +$708K 0.19% 85
2020
Q4
– Sell
-1,150
Closed -$128K – 180
2020
Q3
$128K Buy
+1,150
New +$129K 0.06% 117
2020
Q2
– Sell
-1,150
Closed -$89K – 181
2020
Q1
$89K Hold
1,150
– – 0.04% 140
2019
Q4
$109K Hold
1,150
– – 0.04% 163
2019
Q3
$88K Hold
1,150
– – 0.03% 151
2019
Q2
$101K Buy
+1,150
New +$98.1K 0.04% 145

Other funds holding XBI

Family Management's XBI Position: Q2 2026 in Review

Family Management opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q2 2026: 537 shares worth $85K. The stake represents 0.01% of the portfolio and ranks #291 among its holdings. This is a return to the name: Family Management previously reported a position in XBI as recently as Q1 2025.

Family Management first reported a position in XBI in Q2 2019 and has held it in 18 quarters since. The position peaked at $1.16M in Q1 2024. 936 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

  • Family Management held 537 shares of State Street SPDR S&P Biotech ETF worth $85K as of Q2 2026.
  • State Street SPDR S&P Biotech ETF was a new Family Management position in Q2 2026.
  • State Street SPDR S&P Biotech ETF made up 0.01% of Family Management's portfolio in Q2 2026, its #291 holding.
  • Family Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2019 and has held it in 18 quarters since.
  • Family Management's State Street SPDR S&P Biotech ETF position peaked at $1.16M in Q1 2024.
  • 936 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Family Management's 13F filing for Q2 2026, filed 14 Aug 2026.